RCT for SSLF vs. ISFF With Conventional Surgical Instruments in Chinese Apical Prolapse Female Patients

Sponsor
Peking Union Medical College Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04213027
Collaborator
(none)
320
5
2
72
64
0.9

Study Details

Study Description

Brief Summary

This trial is designed to investigate the efficacy and safety of two native tissue repair procedure with conventional surgical instruments in Chinese apical prolapse female patients (POP-Q II-IV) and compare the outcome in prolapse women randomized to Sacrospinous ligament fixation (SSLF) and Ischial spinous fascia fixation (ISFF).

Condition or Disease Intervention/Treatment Phase
  • Procedure: native tissue repair procedures with conventional surgical instruments
N/A

Detailed Description

The population will include Chinese female patients with advanced apical prolapse (stage II-III) and who are undergoing Sacrospinous Ligament Fixation (SSLF) and Ischial spinous fascia fixation (ISFF) procedure using conventional surgical instruments without special instrument. After enrollment, standardized baseline data including demographics, POPQ evaluation, series of validated questionaires via interviews( PFDI-20, PFIQ-7, PISQ-12) will be collected by study personnel at the baseline visit. Eligible consenting patients will proceed to randomizations with equal probability of assignment to SSLF or ISFF. Randomization to either SSLF or ISFF will take place preoperatively by each clinical site using a random permutated block design. After index surgical intervention, scheduled follow-up will occur at 3, 6, 12, 24 and 36 months after the index surgery. At the follow-up visits, POPQ examination will be performed and an update of current medications, an assessment of new or continuing pelvic floor disorders, adverse events that occurred since the previous evaluation, and an assessment of health care costs. A series of validated instruments will be administered via interviews to including PFDI-20, PFIQ-7, PISQ-12, PGI-C.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
320 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Sacrospinous Ligament Fixation vs. Ischial Spine Fasicia Fixation With Conventional Surgical Instruments in Chinese Apical Prolapse Female Patients: a Multi-center, Prospective, Randomized Clinical Trial
Anticipated Study Start Date :
Jan 1, 2020
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: SSLF-CSI

native tissue repair procedure with conventional surgical instruments in Chinese apical prolapse female patients randomized to Sacrospinous ligament fixation (SSLF) .

Procedure: native tissue repair procedures with conventional surgical instruments
Sacrospinous ligament fixation (SSLF): treatment for apical prolapse with vaginal fornix suspended to sacrospinous ligament; Ischial spinous fascia fixation (ISFF): treatment for apical prolapse with vaginal fornix suspended to ischial spinous fascia (ISFF).

Active Comparator: ISFF-CSI

native tissue repair procedure with conventional surgical instruments in Chinese apical prolapse female patients randomized to Ischial spinous fascia fixation (ISFF)

Procedure: native tissue repair procedures with conventional surgical instruments
Sacrospinous ligament fixation (SSLF): treatment for apical prolapse with vaginal fornix suspended to sacrospinous ligament; Ischial spinous fascia fixation (ISFF): treatment for apical prolapse with vaginal fornix suspended to ischial spinous fascia (ISFF).

Outcome Measures

Primary Outcome Measures

  1. rate of surgical success [up to 36 months after operation]

    definition for surgical success is symptomatic prolapse below grade II occurred at 3 months after operation, and the severest indication point in POP-Q evaluation was taken as the criterion. No vaginal swelling sensation, that is answer "no" for PFDI-20 Questionnaire Question 3, "Do you often see or feel vaginal tumors come out?". The patient's self-perception symptoms is improved or improved significantly, that is answer 1 or 2 for the PGI-C questionnaire. There is no need of further treatment for prolapse, such as reoperation or pessary.

Secondary Outcome Measures

  1. rate of Postoperative recurrence [from 3 months after operation up to 36 months after operation]

    definition for postoperative recurrence is symptomatic prolapse above grade II occurred 3 months after operation, and the severest indication point in POP-Q evaluation was taken as the criterion. Vaginal swelling sensation, that is answer "yes" for PFDI-20 Questionnaire Question 3, "Do you often see or feel vaginal tumors come out?". There is need of further treatment for prolapse, such as reoperation or pessary.

  2. visual analogue scales [up to 36 months after operation, usuallly within 3 days after operation]

    postoperative pain evaluation esp. hip pain by visual analogue scales (VAS). Visual Analogue Scale (VAS) is a self-report measure consisting simply of a 10 centimeter line with a statement at each end representing one extreme of the dimension being measured (most often intensity of pain). VAS result will be reported ranging from 0 to 10, with 0 representing no pain, and 10 representing unbearable severe pain

  3. changes between preoperative and postoperative symptomatic improvement using validated instruments(PFIQ-7) [up to 36 months after operation]

    Relief of symptoms using validated instruments, pelvic floor impact questionnaire short form 7(PFIQ-7)。PFIQ-7 scores 0-300, the higher the severer negative influence on patient.

  4. changes between preoperative and postoperative symptomatic improvement using validated instruments(PFDI-20) [up to 36 months after operation]

    Relief of symptoms using validated instruments, pelvic floor distress inventory short form 20(PFDI-20), PFDI-20 scores 0-300, the higher the severer negative influence on patient.

  5. changes between preoperative and postoperative symptomatic improvement using validated instruments(PISQ-12) [up to 36 months after operation]

    Relief of symptoms using validated instruments, Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire short form(PISQ-12), PISQ-12 scores 0-48, the higher, the severer negative influence on patient.

  6. results of postoperative symptomatic improvement using patient global impression of change (PGI-C) [up to 36 months after operation]

    Relief of symptoms using patient global impression of change (PGI-C), PGI-C scores 1-7, the higher, the the severer negative influence on patient.

  7. intraoperative and post operative complications [up to 36 months after operation]

    using IUGA/ICS joint terminology CTS coding system and dingo system

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Women with apical prolapse with POP-Q II-IV (but no anterior wall prolapse stage IV)

  2. SSLF or ISFF is proceeded as described before,while ancillary procedures like vaginal hysterectomy, anterior/posterior vaginal wall repair without mesh or mid-urethral suspension could be performed simultaneously.

  3. Women who have been eligible for long-term follow-up.

  4. Women who agreed to participate in the study and signed informed consent.

Exclusion Criteria:
  1. Women who have surgical history for prolapse with mesh.

  2. Women who have contraindication for surgical procedure

  3. Women who are unable to comply with the study procedures

Contacts and Locations

Locations

Site City State Country Postal Code
1 2nd Affiliated hospital of Anhui Medical college Hefei Anhui China 230041
2 1st Affiliated hospital of PLA general hospital Beijing Beijing China 100037
3 Peking Union Medical College Hospital Beijing Beijing China 100730
4 Suzhou City Hospital Suzhou Jiangsu China 215008
5 Shanghai First Maternity and Infant Hospital Shanghai Shanghai China 200040

Sponsors and Collaborators

  • Peking Union Medical College Hospital

Investigators

  • Principal Investigator: Yongxian Lu, 1st Affiliated hospital of PLA general hospital
  • Principal Investigator: Zhiyuan Dai, Shanghai First Maternity and Infant Hospital
  • Principal Investigator: Wenyan Wang, 2nd Affiliated hospital of Anhui Medical college
  • Principal Investigator: Zhaoai Li, Shan'xi Province Women's and Children's Hospital
  • Principal Investigator: Yuling Wang, Foshan Women's and Children's Hospital
  • Principal Investigator: Shunyu Hou, Suzhou City Hospital
  • Principal Investigator: Xiangjuan Li, Hangzhou Women's and Children's Hospital
  • Principal Investigator: Lubin Liu, Chongqing Women's and Children's Hospital
  • Principal Investigator: Le Ma, Beijing Obstetrics and Gynecology Hospital
  • Principal Investigator: Tao Xu, Statistics Department of Peking Union Medical College
  • Principal Investigator: Joseph Schaffer, UT Southwestern Medical Center
  • Principal Investigator: Marko J Jachtorowycz, Saint Francis Memorial Hospital
  • Study Chair: Lan Zhu, Peking Union Medical College Hospital
  • Study Director: Yuxin Dai, Peking Union Medical College Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
zhulan, Professor, Peking Union Medical College Hospital
ClinicalTrials.gov Identifier:
NCT04213027
Other Study ID Numbers:
  • PekingUMCH SSLFvsISFF-CSI
First Posted:
Dec 30, 2019
Last Update Posted:
Jan 2, 2020
Last Verified:
Dec 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 2, 2020